Filing Details
- Accession Number:
- 0001209191-19-009642
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-13 16:33:31
- Reporting Period:
- 2019-02-11
- Accepted Time:
- 2019-02-13 16:33:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661567 | Michael Parini | 50 Northern Avenue Boston MA 02210 | Evp, Cl&Ao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-11 | 3,894 | $179.48 | 48,869 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-11 | 5,480 | $180.36 | 43,389 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-11 | 2,762 | $181.00 | 40,627 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $179.48 (range $178.75 to $179.74).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $180.36 (range $179.82 to $180.74).
- Open market sales reported on this line occurred at a weighted average price of $181.00 (range $180.76 to $181.37).
Billionaire Hedge Funds
